Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Top Cited Papers
- 15 January 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (2) , 465-472
- https://doi.org/10.1158/1078-0432.ccr-05-1886
Abstract
Purpose: CD4+ T cells play a central role in initiating and maintaining anticancer immune responses. However, regulatory CD4+CD25+ T cells which express Foxp3 have also been shown to inhibit antitumor effector T cells. In view of these heterogeneous CD4+ T-cell populations, this study was designed to determine the prognostic value of various tumor-infiltrating CD4+ T-cell populations in head and neck squamous cell carcinoma. Experimental Design: Eighty-four newly diagnosed untreated patients with histologically proven primary head and neck squamous cell carcinoma were included in this study. Double or triple immunofluorescence staining was done to assess and quantify the activated CD4+CD69+ T cells, regulatory CD4+Foxp3+ T cells, and mixed CD4+CD25+ T cells comprising both activated and regulatory T cells. Results: On univariate analysis, high levels of tumor-infiltrating CD4+CD69+ T cells were correlated with both better locoregional control (P = 0.01) and longer survival (P = 0.01). Infiltration by regulatory Foxp3+CD4+ T cells was positively associated with a better locoregional control of the tumor. Multivariate analysis showed that the only significant prognostic factors related to locoregional control were T stage (P = 0.02) and CD4+Foxp3+ T-cell infiltration of the tumor (P = 0.02). In the Cox multivariate analysis, only two variables influenced overall survival probability: T stage (P = 0.036) and CD4+CD69+ T-cell infiltration (P = 0.017). Conclusion: This study shows that tumor-infiltrating activated CD4+CD69+ T cells are associated with a good prognosis in head and neck squamous cell carcinoma. In addition, regulatory Foxp3+CD4+ T cells are positively correlated with locoregional control may be through down-regulation of harmful inflammatory reaction, which could favor tumor progression.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Helping the CD8+ T-cell responseNature Reviews Immunology, 2004
- Decreased Absolute Counts of T Lymphocyte Subsets and Their Relation to Disease in Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2004
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- T-Cell Activation Marker Expression on Tumor-Infiltrating Lymphocytes As Prognostic Factor in Cutaneous Malignant MelanomaClinical Cancer Research, 2004
- Identification of NY‐ESO‐1, MAGE‐1, and MAGE‐3 in head and neck squamous cell carcinomaHead & Neck, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or MelanomaThe Journal of Experimental Medicine, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994
- Variations in CD4 Expression by Human Monocytes and Macrophages and Their Relationship to Infection with the Human Immunodeficiency VirusJournal of General Virology, 1989